Treatment of nontuberculous mycobacterial pulmonary disease requires a stepwise and multidisciplinary approach

Introduction Nontuberculous mycobacterial pulmonary disease (NTM-PD) occurs in people with inborn or acquired susceptibility factors. Current treatment guideline recommendations include a watchful waiting strategy, antimycobacterial and surgical treatment, with a comprehensive assessment of clinical, microbiological and radiological factors determining which approach is most suitable.